What is BrightSpring Health Services, Inc.'s earnings per share (EPS)?

BrightSpring Health Services, Inc. (BTSG) reported diluted earnings per share of $0.87 for fiscal year 2025. This represents a 1066.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

BrightSpring Health Services, Inc. Financials

BTSG

Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows BrightSpring Health Services, Inc. (BTSG) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BTSG FY2025 2026-05-01

Profitability is being rebuilt through overhead absorption and lighter financing drag, even as gross margin keeps narrowing.

FY2025’s earnings jump was not a simple margin story: gross margin fell to 11.8% from 12.6%, yet operating margin rose to 2.3% as SG&A fell to 9.5% of revenue from 11.5% and interest expense dropped to $157.3M from $190.5M. That combination says scale is now covering overhead and debt costs more efficiently than the underlying service margin alone would suggest.

The quality of profit changed sharply in FY2025: operating cash flow reached $490.2M versus $189.1M of net income, after FY2024 produced only $23.8M of OCF and -$57.1M of free cash flow. That shift implies reported earnings were no longer being swallowed by working-capital and reinvestment demands.

Balance-sheet posture has become less creditor-dominated: long-term debt fell from $3.33B in FY2023 to $2.46B in FY2025, while equity rose from $584.7M to $1.88B and the current ratio improved from 1.2x to 1.6x. With interest burden down by about $114.6M over that span, a larger share of operating improvement can reach the bottom line instead of servicing debt.

Financial Health Signals

Financial Health Score 45/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of BrightSpring Health Services, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

BrightSpring Health Services, Inc. has an operating margin of 2.3%, meaning the company retains $2 of operating profit per $100 of revenue. This results in a moderate score of 48/100, indicating healthy but not exceptional operating efficiency. This is up from 1.1% the prior year.

Growth

BrightSpring Health Services, Inc.'s revenue surged 28.2% year-over-year to $12.9B, reflecting rapid business expansion. This strong growth earns a score of 89/100.

Leverage

BrightSpring Health Services, Inc. has elevated debt relative to equity (D/E of 1.31), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 11/100, reflecting increased financial risk.

Liquidity

BrightSpring Health Services, Inc.'s current ratio of 1.57 indicates adequate short-term liquidity, earning a score of 43/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

BrightSpring Health Services, Inc. has a free cash flow margin of 3.1%, earning a moderate score of 34/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

BrightSpring Health Services, Inc.'s ROE of 10.1% shows moderate profitability relative to equity, earning a score of 47/100. This is up from 1.3% the prior year.

Altman Z-Score Safe

4.24

BrightSpring Health Services, Inc. scores 4.24, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Strong

7/9

BrightSpring Health Services, Inc. passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

2.59x

For every $1 of reported earnings, BrightSpring Health Services, Inc. generates $2.59 in operating cash flow ($490.2M OCF vs $189.1M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage At Risk

1.9x

BrightSpring Health Services, Inc. earns $1.9 in operating income for every $1 of interest expense ($295.3M vs $157.3M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$12.9B

YoY+28.2%

BrightSpring Health Services, Inc. generated $12.9B in revenue in fiscal year 2025. This represents an increase of 28.2% from the prior year.

EBITDA

$459.5M

YoY+47.1%

BrightSpring Health Services, Inc.'s EBITDA was $459.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 47.1% from the prior year.

Net Income

$189.1M

YoY+821.6%

BrightSpring Health Services, Inc. reported $189.1M in net income in fiscal year 2025. This represents an increase of 821.6% from the prior year.

EPS (Diluted)

$0.87

YoY+1066.7%

BrightSpring Health Services, Inc. earned $0.87 per diluted share (EPS) in fiscal year 2025. This represents an increase of 1066.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$394.7M

YoY+790.7%

BrightSpring Health Services, Inc. generated $394.7M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 790.7% from the prior year.

Cash & Debt

$88.4M

YoY+45.0%

BrightSpring Health Services, Inc. held $88.4M in cash against $2.5B in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

192M

YoY+10.3%

BrightSpring Health Services, Inc. had 192M shares outstanding in fiscal year 2025. This represents an increase of 10.3% from the prior year.

Margins & Returns

Gross Margin

11.8%

YoY-0.8pp

BrightSpring Health Services, Inc.'s gross margin was 11.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.8 percentage points from the prior year.

Operating Margin

2.3%

YoY+1.2pp

BrightSpring Health Services, Inc.'s operating margin was 2.3% in fiscal year 2025, reflecting core business profitability. This is up 1.2 percentage points from the prior year.

Net Margin

1.5%

YoY+1.3pp

BrightSpring Health Services, Inc.'s net profit margin was 1.5% in fiscal year 2025, showing the share of revenue converted to profit. This is up 1.3 percentage points from the prior year.

Return on Equity

10.1%

YoY+8.8pp

BrightSpring Health Services, Inc.'s ROE was 10.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 8.8 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$43.2M

YoY+6542.0%

BrightSpring Health Services, Inc. spent $43.2M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 6542.0% from the prior year.

Capital Expenditures

$95.5M

YoY+18.0%

BrightSpring Health Services, Inc. invested $95.5M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 18.0% from the prior year.

BTSG Income Statement

Metric	FY25	FY24	FY23	FY22
Revenue	$12.9B+28.2%	$10.1B+31.0%	$7.7B+15.9%	$6.6B
Cost of Revenue	N/A	N/A	N/A	N/A
Gross Profit	$1.5B+19.8%	$1.3B+11.2%	$1.1B+5.0%	$1.1B
R&D Expenses	N/A	N/A	N/A	N/A
SG&A Expenses	$1.2B+5.5%	$1.2B+7.2%	$1.1B+16.8%	$925.2M
Operating Income	$295.3M+173.5%	$108.0M+85.7%	$58.1M-51.1%	$118.9M
Interest Expense	$157.3M-17.4%	$190.5M-29.9%	$271.9M+36.1%	$199.8M
Income Tax	$33.1M+225.6%	-$26.4M+16.3%	-$31.5M-195.1%	$33.1M
Net Income	$189.1M+821.6%	$20.5M+113.3%	-$154.6M-186.8%	-$53.9M
EPS (Diluted)	$0.87+1066.7%	$-0.09+93.1%	$-1.31-184.8%	$-0.46

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$3.6B+1.8%	$3.6B+6.5%	$3.3B+5.9%	$3.1B+9.4%	$2.9B+54.9%	$1.9B-36.1%	$2.9B+6.5%	$2.7B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	$2.5B+6.7%	$2.3B
Gross Profit	$482.2M+16.9%	$412.5M+5.2%	$392.0M+4.6%	$374.9M+10.8%	$338.4M-0.1%	$338.7M+4.8%	$323.1M+3.5%	$312.2M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$360.8M+18.5%	$304.4M+0.1%	$304.2M-6.8%	$326.3M+13.4%	$287.6M+1.6%	$283.1M-3.7%	$294.0M+7.5%	$273.5M
Operating Income	$121.4M+12.3%	$108.1M+23.1%	$87.8M+80.9%	$48.6M-4.3%	$50.7M-8.6%	$55.5M+90.9%	$29.1M-24.7%	$38.7M
Interest Expense	$38.6M+0.2%	$38.5M+0.8%	$38.2M-1.4%	$38.8M-7.1%	$41.8M-9.6%	$46.2M-0.9%	$46.6M+7.7%	$43.3M
Income Tax	$8.6M-57.3%	$20.0M+65.2%	$12.1M+879.0%	$1.2M+615.8%	-$240K-104.7%	$5.1M-37.7%	$8.2M+162.2%	-$13.1M
Net Income	$148.8M+97.0%	$75.5M+35.3%	$55.8M+97.9%	$28.2M-4.5%	$29.5M-45.9%	$54.6M+763.2%	-$8.2M-141.3%	$19.9M
EPS (Diluted)	$0.67	N/A	$0.26+100.0%	$0.13-7.1%	$0.14	N/A	$-0.04-140.0%	$0.10

BTSG Balance Sheet

Metric	FY25	FY24	FY23	FY22
Total Assets	$6.4B+8.2%	$5.9B+7.1%	$5.5B	N/A
Current Assets	$2.9B+52.9%	$1.9B+30.0%	$1.5B	N/A
Cash & Equivalents	$88.4M+45.0%	$61.0M+390.4%	$12.4M-5.9%	$13.2M
Inventory	$815.2M+28.1%	$636.6M+59.6%	$398.9M	N/A
Accounts Receivable	$989.7M+9.6%	$902.8M+17.7%	$766.9M	N/A
Goodwill	$2.5B+7.7%	$2.4B+2.7%	$2.3B+1.4%	$2.3B
Total Liabilities	$4.5B+5.9%	$4.3B-13.1%	$4.9B	N/A
Current Liabilities	$1.8B+29.5%	$1.4B+14.4%	$1.2B	N/A
Long-Term Debt	$2.5B-4.2%	$2.6B-23.1%	$3.3B	N/A
Total Equity	$1.9B+13.8%	$1.6B+181.8%	$584.7M-22.5%	$754.8M
Retained Earnings	-$74.6M+66.4%	-$222.2M-10.9%	-$200.3M	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$6.2B-3.1%	$6.4B+6.0%	$6.0B+1.8%	$5.9B+1.7%	$5.8B-1.3%	$5.9B+2.4%	$5.8B+3.2%	$5.6B
Current Assets	$2.7B-7.1%	$2.9B+4.1%	$2.8B+5.0%	$2.6B+4.7%	$2.5B+33.6%	$1.9B+10.7%	$1.7B+12.3%	$1.5B
Cash & Equivalents	$888.8M+905.8%	$88.4M-37.0%	$140.3M+100.3%	$70.1M+33.9%	$52.3M-14.1%	$61.0M+69.4%	$36.0M+43.7%	$25.0M
Inventory	$560.2M-31.3%	$815.2M+27.5%	$639.2M+2.2%	$625.5M+17.2%	$533.6M-16.2%	$636.6M+33.1%	$478.3M+27.8%	$374.3M
Accounts Receivable	$1.1B+12.5%	$989.7M-2.3%	$1.0B+4.1%	$972.7M-0.3%	$975.3M+8.0%	$902.8M-12.0%	$1.0B+4.2%	$984.8M
Goodwill	$2.5B-0.5%	$2.5B+7.4%	$2.4B0.0%	$2.4B0.0%	$2.4B+0.3%	$2.4B-11.6%	$2.7B+1.8%	$2.6B
Total Liabilities	$4.2B-6.7%	$4.5B+7.1%	$4.2B+0.7%	$4.2B+1.0%	$4.2B-2.8%	$4.3B+2.6%	$4.2B+4.2%	$4.0B
Current Liabilities	$1.5B-16.3%	$1.8B+19.3%	$1.5B+3.0%	$1.5B+3.3%	$1.5B+2.1%	$1.4B+13.0%	$1.3B+10.4%	$1.1B
Long-Term Debt	$2.4B-0.4%	$2.5B-0.4%	$2.5B-0.5%	$2.5B-0.5%	$2.5B-2.8%	$2.6B-1.8%	$2.6B+1.8%	$2.6B
Total Equity	$2.0B+5.6%	$1.9B+3.1%	$1.8B+4.3%	$1.7B+3.3%	$1.7B+2.4%	$1.6B+2.0%	$1.6B+1.0%	$1.6B
Retained Earnings	$14.1M+118.9%	-$74.6M+31.2%	-$108.6M+34.0%	-$164.4M+14.6%	-$192.6M+13.3%	-$222.2M+5.2%	-$234.4M-3.6%	-$226.2M

BTSG Cash Flow Statement

Metric	FY25	FY24	FY23	FY22
Operating Cash Flow	$490.2M+1961.8%	$23.8M-88.7%	$210.8M+4630.0%	-$4.7M
Capital Expenditures	$95.5M+18.0%	$80.9M+10.0%	$73.5M+4.9%	$70.1M
Free Cash Flow	$394.7M+790.7%	-$57.1M-141.6%	$137.3M+283.6%	-$74.8M
Investing Cash Flow	-$305.1M-117.5%	-$140.2M-4.3%	-$134.4M-396.4%	$45.4M
Financing Cash Flow	-$157.9M-195.9%	$164.6M+314.1%	-$76.9M-4.2%	-$73.8M
Dividends Paid	N/A	N/A	N/A	N/A
Share Buybacks	$43.2M+6542.0%	$650K0.0%	$650K	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	$122.9M-46.9%	$231.6M+114.5%	$107.9M+119.9%	$49.1M-51.7%	$101.6M+12.1%	$90.6M+232.6%	$27.2M+279.0%	-$15.2M
Capital Expenditures	$21.5M-42.8%	$37.7M+139.0%	$15.8M-35.5%	$24.4M+38.5%	$17.6M+15.2%	$15.3M-23.6%	$20.0M-15.6%	$23.7M
Free Cash Flow	$101.4M-47.7%	$193.9M+110.4%	$92.2M+273.9%	$24.7M-70.6%	$84.0M+11.5%	$75.3M+945.4%	$7.2M+118.5%	-$39.0M
Investing Cash Flow	$747.4M+419.6%	-$233.9M-884.3%	-$23.8M-2.2%	-$23.2M+3.9%	-$24.2M-53.3%	-$15.8M+56.0%	-$35.8M+37.9%	-$57.7M
Financing Cash Flow	-$70.0M-38.7%	-$50.5M-285.3%	-$13.1M-59.0%	-$8.2M+90.4%	-$86.0M-73.6%	-$49.6M-353.8%	$19.5M-51.1%	$39.9M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$60.0M	N/A	N/A	N/A	N/A	$0	$0-100.0%	$325K

BTSG Financial Ratios

Metric	FY25	FY24	FY23	FY22
Gross Margin	11.8%-0.8pp	12.6%-2.2pp	14.8%-1.5pp	16.4%
Operating Margin	2.3%+1.2pp	1.1%+0.3pp	0.8%-1.0pp	1.8%
Net Margin	1.5%+1.3pp	0.2%+2.2pp	-2.0%-1.2pp	-0.8%
Return on Equity	10.1%+8.8pp	1.3%+27.7pp	-26.4%-19.3pp	-7.1%
Return on Assets	2.9%+2.6pp	0.4%+3.1pp	-2.8%	N/A
Current Ratio	1.57+0.2	1.33+0.2	1.17	N/A
Debt-to-Equity	1.31-0.2	1.55-4.1	5.70	N/A
FCF Margin	3.1%+3.6pp	-0.6%-2.4pp	1.8%+2.9pp	-1.1%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	13.3%+1.7pp	11.6%-0.1pp	11.8%-0.2pp	11.9%+0.2pp	11.8%-6.5pp	18.2%+7.1pp	11.1%-0.3pp	11.4%
Operating Margin	3.4%+0.3pp	3.0%+0.4pp	2.6%+1.1pp	1.5%-0.2pp	1.8%-1.2pp	3.0%+2.0pp	1.0%-0.4pp	1.4%
Net Margin	4.1%+2.0pp	2.1%+0.5pp	1.7%+0.8pp	0.9%-0.1pp	1.0%-1.9pp	2.9%+3.2pp	-0.3%-1.0pp	0.7%
Return on Equity	7.5%+3.5pp	4.0%+1.0pp	3.1%+1.5pp	1.6%-0.1pp	1.8%-1.6pp	3.3%+3.8pp	-0.5%-1.8pp	1.3%
Return on Assets	2.4%+1.2pp	1.2%+0.3pp	0.9%+0.4pp	0.5%-0.0pp	0.5%-0.4pp	0.9%+1.1pp	-0.1%-0.5pp	0.4%
Current Ratio	1.74+0.2	1.57-0.2	1.79+0.0	1.76+0.0	1.73+0.4	1.33-0.0	1.35+0.0	1.33
Debt-to-Equity	1.24-0.1	1.31-0.0	1.36-0.1	1.42-0.1	1.48-0.1	1.55-0.1	1.62+0.0	1.60
FCF Margin	2.8%-2.7pp	5.5%+2.7pp	2.8%+2.0pp	0.8%-2.1pp	2.9%-1.1pp	4.0%+3.8pp	0.3%+1.7pp	-1.4%

Similar Companies

Waystar Holding Corp. WAY

$4.3B

Healthequity Inc HQY

$7.9B

Privia Health Group, Inc. PRVA

$3.2B

PGIM Securitized Income ETF PINC

$2.3B

Omnicell Com OMCL

$1.9B

Frequently Asked Questions

What is BrightSpring Health Services, Inc.'s annual revenue?

BrightSpring Health Services, Inc. (BTSG) reported $12.9B in total revenue for fiscal year 2025. This represents a 28.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is BrightSpring Health Services, Inc.'s revenue growing?

BrightSpring Health Services, Inc. (BTSG) revenue grew by 28.2% year-over-year, from $10.1B to $12.9B in fiscal year 2025.

Is BrightSpring Health Services, Inc. profitable?

Yes, BrightSpring Health Services, Inc. (BTSG) reported a net income of $189.1M in fiscal year 2025, with a net profit margin of 1.5%.

What is BrightSpring Health Services, Inc.'s EBITDA?

BrightSpring Health Services, Inc. (BTSG) had EBITDA of $459.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does BrightSpring Health Services, Inc. have?

As of fiscal year 2025, BrightSpring Health Services, Inc. (BTSG) had $88.4M in cash and equivalents against $2.5B in long-term debt.

What is BrightSpring Health Services, Inc.'s gross margin?

BrightSpring Health Services, Inc. (BTSG) had a gross margin of 11.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is BrightSpring Health Services, Inc.'s operating margin?

BrightSpring Health Services, Inc. (BTSG) had an operating margin of 2.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is BrightSpring Health Services, Inc.'s net profit margin?

BrightSpring Health Services, Inc. (BTSG) had a net profit margin of 1.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is BrightSpring Health Services, Inc.'s return on equity (ROE)?

BrightSpring Health Services, Inc. (BTSG) has a return on equity of 10.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is BrightSpring Health Services, Inc.'s free cash flow?

BrightSpring Health Services, Inc. (BTSG) generated $394.7M in free cash flow during fiscal year 2025. This represents a 790.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is BrightSpring Health Services, Inc.'s operating cash flow?

BrightSpring Health Services, Inc. (BTSG) generated $490.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are BrightSpring Health Services, Inc.'s total assets?

BrightSpring Health Services, Inc. (BTSG) had $6.4B in total assets as of fiscal year 2025, including both current and long-term assets.

What are BrightSpring Health Services, Inc.'s capital expenditures?

BrightSpring Health Services, Inc. (BTSG) invested $95.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does BrightSpring Health Services, Inc. buy back shares?

Yes, BrightSpring Health Services, Inc. (BTSG) spent $43.2M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does BrightSpring Health Services, Inc. have outstanding?

BrightSpring Health Services, Inc. (BTSG) had 192M shares outstanding as of fiscal year 2025.

What is BrightSpring Health Services, Inc.'s current ratio?

BrightSpring Health Services, Inc. (BTSG) had a current ratio of 1.57 as of fiscal year 2025, which is generally considered healthy.

What is BrightSpring Health Services, Inc.'s debt-to-equity ratio?

BrightSpring Health Services, Inc. (BTSG) had a debt-to-equity ratio of 1.31 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is BrightSpring Health Services, Inc.'s return on assets (ROA)?

BrightSpring Health Services, Inc. (BTSG) had a return on assets of 2.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is BrightSpring Health Services, Inc.'s Altman Z-Score?

BrightSpring Health Services, Inc. (BTSG) has an Altman Z-Score of 4.24, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is BrightSpring Health Services, Inc.'s Piotroski F-Score?

BrightSpring Health Services, Inc. (BTSG) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are BrightSpring Health Services, Inc.'s earnings high quality?

BrightSpring Health Services, Inc. (BTSG) has an earnings quality ratio of 2.59x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can BrightSpring Health Services, Inc. cover its interest payments?

BrightSpring Health Services, Inc. (BTSG) has an interest coverage ratio of 1.9x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is BrightSpring Health Services, Inc.?

BrightSpring Health Services, Inc. (BTSG) scores 45 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.